Pharmaceuticals: Management Safety of Circulation of Drugs

Author:

Kharytonova GannaORCID

Abstract

The adoption and implementation of EU pharmaceutical directives and regulatory documents in Ukraine will significantly enhance the level of public health protection. Establishing a unified pharmaceutical market with EU countries will also improve the safety, quality, and accessibility of medications in Ukraine. To achieve these objectives, a comprehensive system for managing drug circulation safety has been proposed, with detailed functions and roles elaborated. Key components of this safety management system include robust monitoring mechanisms, stringent regulatory compliance measures, and effective communication channels among stakeholders. By implementing these measures, Ukraine can ensure that drugs are safe, effective, and of high quality, thereby fostering greater public trust in the healthcare system. Additionally, the integration of advanced technologies and best practices from EU countries can streamline drug approval processes, reduce counterfeit medications, and enhance pharmacovigilance. Efforts to improve the circulation of drugs will not only guarantee their safety and quality but also make them more readily available to the population. This will involve upgrading infrastructure, enhancing regulatory frameworks, and fostering collaboration with international pharmaceutical organizations. Overall, these initiatives are crucial for aligning Ukraine's pharmaceutical sector with European standards, ultimately leading to better health outcomes for its citizens and a more resilient healthcare system.

Publisher

Shapovalov Scientific Publishing OU (Publications)

Reference55 articles.

1. Pignattі F., Boone H., Moulon I. Overview of the European regulatory approval system. J. Ambul. Care Manage. 2004. Vol. 27. No. 2. P. 89-97. DOI: 10.1097/00004479-200404000-00003

2. Pharmaceuticals: EU Regulations [6.0 RAC]. RAPS. 2024. URL: https://www.raps.org/products/pharmaceuticals-eu-regulations-60-rac

3. Health and social responses to drug problems: a European guide. EMCDDA. October 2021. URL: https://www.emcdda.europa.eu/publications/health-and-social-responses-a-european-guide_en

4. Medicine in the UK: from each – whenever possible, for everyone – on demand. https://www.vz.kiev.ua/medytsyna-velykoyi-brytaniyi-vid-kozhnogo-po-mozhlyvosti-kozhnomu-po-potrebi/

5. Shapovalov V.V.(Jr.), Shapovalova V.O., Shapovalov V.V. Experience of Great Britain in organization of healthcare system for pharmaceutical provision with medicines for privileged categories of citizens. Health of society. 2019. Vol. 78. No. 1. P. 36–40. URL: https://health-society.zaslavsky.com.ua/index.php/journal/article/view/188

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3